Lessons from barrenness about a controversial issue, part III
Published in Christian Renewal magazine, 30 January 2007
The reason for the controversy surrounding stem cell research is straightforward: if human life begins at conception, and if human life is intrinsically valuable and therefore to be preserved whenever possible—which were the two conclusions of the previous article in this series—then the procedures common to embryonic stem cell research, which involve the termination of human life, are inherently wrong.
Does this mean that a person who believes that life begins at conception should oppose stem cell research and its potential for treating serious diseases? Although it is rarely mentioned in the public discourse on the subject, there is a solution to this controversy that both promotes research and protects human life.
The problem
By the fifth day after conception, a fertilized egg will have multiplied into about 200 cells. An embryo at this stage is called a blastocyst and is made up of two main parts: the outer cell mass and the inner cell mass. A blastocyst’s outer cell mass expands into the placenta, while all the various components of a fetal body will grow from the inner cell mass.
It is these inner cells that are the embryonic stem cells. They intrigue medical researchers—from this one kind of cell comes all the diverse parts in the human body, from muscle and bone to brain and skin cells. The hope is that embryonic stem cells can be manipulated into any kind of tissue, making them able to treat disease by replacing diseased or damaged tissue anywhere in the body. For example, stem cells could be injected into a heart that has been damaged by a heart attack in order to increase healthy tissue and strengthen the heart.
The controversy concerning embryonic stem cell research is the method used for collecting the stem cells, which involves removing the inner cell mass from a blastocyst. If the collection is done properly, these stem cells will repeatedly divide and researchers will have a successful stem cell line that will supply them with cells indefinitely. However, the removal of the inner cell mass essentially destroys the blastocyst. Consequently, if human life begins at conception, then the method for collecting embryonic stem cells destroys human life.
Whenever such an opinion is expressed, however, the counter argument is quickly raised: if you care so much about human life, what about the lives of the sick and dying who could be cured by embryonic stem cell research? Unfortunately, this is a very misguided question. Not only does it pit the life of an embryo against an ill person’s life, far too often the promise of embryonic stem cell research is overstated and its inherent problems are unduly minimized.
The hope of stem cell research is a cure for some of the most serious diseases known to man. This hope, however, is still only a theoretical possibility. Perhaps stem cells can be manipulated into any number of cell types, but perhaps not—there is no guarantee that this can be accomplished. Even if stem cells are introduced into an ill person’s body, they might not improve its condition at all. A January 2004 report on stem cell research by the President’s Council on Bioethics (http://www.bioethics.gov/reports/stemcell/chapter1.html), states,
"There are also sensitive issues regarding premature claims of cures for diseases that are not scientifically substantiated and the potential exploitation of sick people and their families. Some advocates of stem cell research have made bold claims about the number of people who will be helped should the research go forward, hoping to generate sympathy for increased research funding among legislators and the public. A few advocates have gone so far as to blame (in advance) opponents of embryonic stem cell research for those who will die unless the research goes forward today. At the same time, other scientists have cautioned that the pace of progress will be very slow, and that no cures can be guaranteed in advance. Which of these claims and counterclaims is closer to the truth cannot be known ahead of time. Only once the proper scientific studies are conducted will we discover the potential therapeutic value of stem cells from any source. How, then, in the meantime should we discuss these matters, offering encouragement but without misleading or exploiting the fears and hopes of the desperately ill?"
Overstatement of the promise of embryonic stem cell research is often a case of political propaganda. This was seen clearly in a recent television ad in which Michael J. Fox advocated Claire McCaskill for US Senate. Mr. Fox says that Ms. McCaskill “shares my hope for cures,” but her opponent, Jim Talent, wants “to criminalize the science that gives us a chance for hope.” In the world of politics, a conviction to defend human life (that is, opposition to stem cell research) can equal a disregard for human life both physically (opposing cures) and emotionally (opposing hope). As is too often the case, those who are most vulnerable—in this case, the seriously ill and the tiniest humans—have become fodder for a broader political struggle. The next article in this series will examine more thoroughly the politics of stem cell research.
Even more frequently, the potential problems stem cell treatment might cause are understated. Instead of a cure, it might cause even more problems for the patient. For example, researchers fear that the introduction of stem cells into a human body might cause a tumor or that the body might reject them. Caution must temper optimism when it is yet unknown whether research will produce a cure or cause an even greater problem.
One final problem with embryonic stem cell research is the inefficiency with which embryonic stem cells are collected. If the collection is done properly, a new line of stem cells is created which can multiply indefinitely. However, according to a May 2003 report by the Ethics Committee of the American Society for Reproductive Medicine, 11,283 embryos had been donated to research, but it is estimated that only about 275 stem cell lines could be created from that number (http://www.asrm.org/Professionals/Fertility&Sterility/cryoembryos_may2003.pdf). This success rate of about 2.5% means that 97.5% of embryos used in research are destroyed without producing any stem cells at all.
Where do these facts leave us? Do these problems mean that we must abandon stem cell research if we believe that embryos are human beings and therefore should be preserved? By supporting the tiniest form of human life, are we forsaking the seriously ill who are looking to stem cell research for cures?
Fortunately, there is a solution to the ethical problems regarding embryonic stem cell research. Unfortunately, few people even know this solution exists.
Embryonic stem cells are not the only kind of stem cells. There are other kinds, and they are collected in such a way that does not destroy human life. Consequently, a distinction must be made between embryonic stem cell research and its alternatives.
The first alternative to embryonic stem cells is adult stem cells. Scientists have been researching adult stem cells for about 40 years; they have already been identified in bone marrow, the mammary gland, fat, and nasal tissue. Research concerning sources of adult stem cells is ongoing. For example, Medical News Today reported on December 24, 2006, the discovery of adult stem cells in hair follicles that “demonstrated several desirable characteristics” of being able to repair damage to nerve pathways and sheaths.
Adult stem cells have been successfully differentiated into bone, cartilage, fat, muscle, and other tissue, and have already been successfully used to treat leukemia, heart attack victims, cancer, multiple sclerosis, Crohn’s disease, stroke, anemia, immunodeficiency, liver disorder, and Parkinson’s disease. Since adult stem cells can be harvested from the patient, the immune system will not reject them.
Researchers consider adult stem cells to be inferior to embryonic stem cells for three reasons. First, there are a number of different kinds of adult stem cells; each is found in a different area of the body and is only able to develop into certain kinds of tissue. Because embryonic stem cells have the potential to become any kind of cell and adult stem cells require extra research to locate each kind, adult stem cells are potentially more expensive and less useful for treating disease than embryonic stem cells. However, scientists continue to discover more kinds of adult stem cells, and as stated previously, the collection of a useful embryonic stem cell line is not an efficient process.
Second, embryonic stem cells are capable of reproducing indefinitely, but researchers have found the reproductive ability of adult stem cells to be both slower and more limited in duration.
Third, adult stem cells might contain more DNA abnormalities than embryonic stem cells due to sunlight exposure and toxins absorbed into the body.
Despite these drawbacks, the usefulness of adult stem cells is universally recognized. Researchers have already had tremendous success using adult stem cells—significantly more, in fact, than embryonic stem cells. For an excellent list of how adult stem cells are already being used to treat serious illness, see http://www.lifeissues.org/cloningstemcell/adultstemsuccess.htm.
Several other alternatives to embryonic stem cells exist; they are less researched than adult stem cells, but they are considered to have perhaps an even greater potential. One such alternative is cord blood stem cells, which can be collected from a baby’s umbilical cord after birth. According to a NewScientist.com news report on August 18, 2005, cord blood stem cells have “clinical potential matching that of the far more controversial embryonic stem cells.” Another alternative was only recently discovered. On January 8, 2007, the Associated Press reported the discovery of stem cells in amniotic fluid that “hold much the same promise as embryonic stem cells."
Some of the same problems for research exist among alternatives to embryonic stem cells, and again, it is important to not overstate their promise. But none of them involves destroying embryos.
A person who believes that life begins at conception does not have to—indeed, should not—oppose stem cell research. That person can, however, insist that it is done in a way that protects human life and does not take one life in the hope of saving another. Those who are ill and hoping for a cure do not have to choose between losing hope and taking life. Opponents of embryonic stem cell research should never be accused of criminalizing cures and hope. In fact, the truly blamable are those who push embryonic stem cell research at any cost; though they could promote research that is equally effective while preserving human life, they insist on doing otherwise.
Although stem cell research is an often controversial, convoluted, and politically and emotionally driven issue, its solution is straightforward: in the interest of preserving all varieties of human life, embryonic stem cell research should be abandoned, and all the resources that have been expended to advocate it in the scientific, political, and public arenas should be applied instead to researching cures for diseases using the several equally promising alternatives to embryonic stem cells.
